Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Valentina, Ceni"'
Autor:
Capozzi, Vito Andrea, Valentina, Ceni, Giulio, Sozzi, Alessandra, Cianciolo, Giulia, Gambino, Giulia, Armano, Vito, Chiantera, Roberto, Berretta
Publikováno v:
In Taiwanese Journal of Obstetrics & Gynecology January 2021 60(1):31-35
Autor:
Domenica Lorusso, Valentina Ceni, Gennaro Daniele, Antonella Pietragalla, Vanda Salutari, Margherita Muratore, Camilla Nero, Francesca Ciccarone, Giovanni Scambia
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 2, Iss 1, Pp 48-64 (2021)
Immunotherapy has changed the natural history of several malignancies that, a decade ago, had a very poor prognosis, such as lung cancer and melanoma. Consequently, many attempts have been done to expand the indications of immunotherapy agents, predo
Externí odkaz:
https://doaj.org/article/f2df47e6aecd4eea87f02cf9e94bbfb3
Autor:
Carmine Conte, F. Raspagliesi, Giovanni Scambia, A. Ditto, Valentina Ceni, Claudia Marchetti, Laura Vertechy, Anna Fagotti, Gabriella Ferrandina, Elena Giudice, Domenica Lorusso, G. Bolomini
Publikováno v:
Gynecologic Oncology. 159:95-100
Objective The aim of this study was to investigate the correlation between BRCA mutational status and response to bevacizumab in a large advanced ovarian cancer (AOC) series. Methods This is a multicenter, retrospective case-control study including u
Autor:
Luciano Monfardini, M Gaiano, Alessandra Cianciolo, Vito Andrea Capozzi, Diana Butera, Valentina Ceni, Roberto Berretta
Publikováno v:
Journal of Obstetrics and Gynaecology Research. 46:2221-2236
Objective This review aims to analyze the pathological aspects, diagnosis and treatment of rare mesenchymal uterine tumors. Methods On August 2019, a systematic review of the literature was done on Pubmed, MEDLINE, Scopus, and Google Scholar search e
Autor:
Giovanni Scambia, Gennaro Daniele, Antonella Pietragalla, Margherita Muratore, Valentina Ceni, Vanda Salutari, Camilla Nero, Francesca Ciccarone, Vittoria Carbone, Domenica Lorusso
Publikováno v:
Expert opinion on emerging drugs. 25(4)
In recent years, ovarian cancer (OC) treatment has been enriched with many new target therapies, most of all antiangiogenic drugs and PARP inhibitors (PARPis), which have literally changed the natural history of the disease. The impressive results of
Autor:
Antonella Pietragalla, Giovanni Scambia, Vanda Salutari, Camilla Nero, Gennaro Daniele, Margherita Muratore, Valentina Ceni, Francesca Ciccarone, Domenica Lorusso
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 2, Iss 1, Pp 48-64 (2021)
Immunotherapy has changed the natural history of several malignancies that, a decade ago, had a very poor prognosis, such as lung cancer and melanoma. Consequently, many attempts have been done to expand the indications of immunotherapy agents, predo
Autor:
Marcello Ceccaroni, Matteo Riccò, Maurizio Di Serio, Valentina Ceni, Giulio Sozzi, Giovanna Giordano, Roberto Berretta, Federico Marchesi, Lavinia Volpi, Vito Andrea Capozzi, Michela Monica, Mauro Melpignano
Publikováno v:
Archives of Gynecology and Obstetrics. 297:997-1004
The aim of this retrospective study is to analyze the prognostic role and the practical implication of mesenteric lymph nodes (MLN) involvements in advanced ovarian cancer (AOC). A total of 429 patients with AOC underwent surgery between December 200
Autor:
Carla Merisio, Alessandra Cianciolo, Vito Andrea Capozzi, Giulio Sozzi, Luciano Monfardini, Giulia Gambino, Martina Pugliese, Roberto Berretta, Valentina Ceni, Giulia Armano, M Gaiano
Publikováno v:
ePoster.
Introduction/Background Obesity represents a major health problem. Several studies reported that morbid obesity is associated with an 81% greater health care expenditure per capita compared with normal weight adults in the US. Although many articles
Autor:
G. Morganelli, Giulia Armano, Roberto Berretta, Luciano Monfardini, Giulia Gambino, Valentina Ceni, Martina Pugliese, Alessandra Cianciolo, M Gaiano, Vito Andrea Capozzi, Martino Rolla, Giulio Sozzi, Carla Merisio
Publikováno v:
ePoster.
Introduction/Background Endometrial cancer is the most frequently diagnosed gynecological tumor with more than 60.000 new cases each year. Following the ESMO-ESGO-ESTRO consensus conference, patients are classified in different classes of risk for ly
Autor:
Giulia Armano, Vito Andrea Capozzi, M Gaiano, Alessandra Cianciolo, Giulia Gambino, Luciano Monfardini, Martino Rolla, Giulio Sozzi, Martina Pugliese, Carla Merisio, Valentina Ceni, Roberto Berretta
Publikováno v:
ePoster.
Introduction/Background Vulvar cancer often requires radical vulvectomy with subsequent vulvar flap due to tumor aggressiveness and a high percentage of relapses. Approximately in 20–60% of cases, there are post-operative complications ranging from